FDA Clears Tumor Profiling Assay that Analyzes 425 Cancer-Related Genes
The NGS-based test joins CE-IVD and NMPA approvals for global market access.
Category: Molecular Diagnostics
Molecular Diagnostics
Latest
Molecular Diagnostics
Latest
Shed Launches At-Home Genetic Testing Kits Focused on Health and Wellness Applications
The Salt Lake City-based company offers four targeted testing options that focus on how genetics influence responses to nutrition, fitness, sleep, and stress management.
Molecular Diagnostics
Latest
Implementing Long-Read Sequencing in Clinical Labs
As accessibility to long-read sequencing technologies like Oxford Nanopore and PacBio increases, clinical laboratories must assess their readiness for implementation.
Oncomine Dx Express Test Receives FDA Approval as a Companion Diagnostic
The FDA has approved Thermo Fisher’s Oncomine Dx Express Test on the Genexus Dx Integrated Sequencer as a companion diagnostic for ZEGFROVY.
Read More
CRISPR-Cas10 Integrated with Graphene Field-Effect Transistors Offer Innovative RNA Detection Approach
Researchers have developed a CRISPR-Cas10-integrated graphene biosensor for amplification-free, ultra-sensitive RNA and miRNA detection.
Read More
SeqOnce Biosciences Adds RT-qPCR Measles Panel
SeqOnce has launched Measles Panel A, a new RT-qPCR assay designed to detect all known measles genotypes—including the D8 genotype.
Read More
Seegene Launches STAgora for Infectious Disease Analytics
Seegene has launched STAgora, a next-gen infectious disease analytics platform providing real-time, AI-driven insights.
Read More
PanTracer Tissue and PanTracer Tissue + HRD Are Now Available
NeoGenomics has launched PanTracer Tissue and PanTracer Tissue + HRD, advanced solid tumor profiling assays.
Read More
The Diagnostic Revolution That Could Finally Deliver on the Promise of Precision Medicine—And Why Medical Training Must Catch UpÂ
Despite powerful advances in precision medicine, most doctors remain untrained in these emerging diagnostic tools.
Read More
Blood Test May Detect Leukemia Risk
A new study reveals that a simple blood test using single-cell sequencing of rare stem cells can detect early signs of leukemia.
Read More
How NGS-Based MRD Is Reshaping Hematological Malignancy Management
NGS-based MRD testing offers unprecedented sensitivity and breadth in detecting low-frequency leukemic clones.
Read More
Saliva Analysis Could Reveal Disease Risk
A study shows that saliva contains genetic markers linked to systemic diseases for a non-invasive alternative to blood-based diagnostics.
Read More
Rapid NGS Technology Accelerates Clinical Trial Breakthroughs in Oncology
Precision oncology is undergoing rapid transformation driven by NGS technology, but systemic barriers in testing access must be overcome.
Read More
Genetic Testing for Children with Autism Remains Rare in Medicaid
Most Medicaid-enrolled children with autism or intellectual disability are not receiving recommended genetic testing.
Read More
Nanopore Sensing Platform Developed
Researchers have developed a nanopore sensor using 2D materials, marking a breakthrough toward DNA sequencing for precision medicine.
Read More
Genetic Mutation Detected with Testing Device
Rutgers and Yale engineers have developed a portable device that rapidly detects rare genetic mutations from a single drop of blood.
Read More
Healthspan Proteomic Score Predicts Lifetime Disease Risk
Researchers have developed a blood-based Healthspan Proteomic Score (HPS) that predicts biological aging and risk of chronic diseases.
Read More
Key Genes ID’d as Cause of Complex Diseases
Researchers have developed a generative AI tool, TWAVE, that identifies networks of genes responsible for complex diseases.
Read More